Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.
Identifieur interne : 000507 ( an2020/Analysis ); précédent : 000506; suivant : 000508Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.
Auteurs : G. Kampf [Allemagne] ; D. Todt [Allemagne] ; S. Pfaender [Allemagne] ; E. Steinmann [Allemagne]Source :
- The Journal of hospital infection [ 1532-2939 ] ; 2020.
Descripteurs français
- KwdFr :
- MESH :
- pharmacologie : Désinfectants.
- transmission : Humains, Infections à coronavirus, Microbiologie de l'environnement, Pneumopathie virale, Viabilité microbienne.
English descriptors
- KwdEn :
- MESH :
- chemical , pharmacology : Disinfectants.
- drug effects : Betacoronavirus.
- growth & development : Betacoronavirus.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- Environmental Microbiology, Humans, Microbial Viability.
Abstract
Currently, the emergence of a novel human coronavirus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for SARS-CoV-2, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread.
DOI: 10.1016/j.jhin.2020.01.022
PubMed: 32035997
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000B79
- to stream PubMed, to step Curation: 000B79
- to stream PubMed, to step Checkpoint: 000468
- to stream Ncbi, to step Merge: 000979
- to stream Ncbi, to step Curation: 000979
- to stream Ncbi, to step Checkpoint: 000979
- to stream Main, to step Merge: 000509
- to stream Main, to step Curation: 000507
- to stream Main, to step Exploration: 000507
- to stream an2020, to step Extraction: 000507
Links to Exploration step
pubmed:32035997Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.</title><author><name sortKey="Kampf, G" sort="Kampf, G" uniqKey="Kampf G" first="G" last="Kampf">G. Kampf</name><affiliation wicri:level="1"><nlm:affiliation>University Medicine Greifswald, Institute for Hygiene and Environmental Medicine, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany. Electronic address: guenter.kampf@uni-greifswald.de.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>University Medicine Greifswald, Institute for Hygiene and Environmental Medicine, Ferdinand-Sauerbruch-Straße, 17475 Greifswald</wicri:regionArea><wicri:noRegion>17475 Greifswald</wicri:noRegion><wicri:noRegion>17475 Greifswald</wicri:noRegion><wicri:noRegion>17475 Greifswald</wicri:noRegion></affiliation></author><author><name sortKey="Todt, D" sort="Todt, D" uniqKey="Todt D" first="D" last="Todt">D. Todt</name><affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum</wicri:regionArea><wicri:noRegion>44801 Bochum</wicri:noRegion><wicri:noRegion>44801 Bochum</wicri:noRegion><wicri:noRegion>44801 Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Pfaender, S" sort="Pfaender, S" uniqKey="Pfaender S" first="S" last="Pfaender">S. Pfaender</name><affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum</wicri:regionArea><wicri:noRegion>44801 Bochum</wicri:noRegion><wicri:noRegion>44801 Bochum</wicri:noRegion><wicri:noRegion>44801 Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Steinmann, E" sort="Steinmann, E" uniqKey="Steinmann E" first="E" last="Steinmann">E. Steinmann</name><affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum</wicri:regionArea><wicri:noRegion>44801 Bochum</wicri:noRegion><wicri:noRegion>44801 Bochum</wicri:noRegion><wicri:noRegion>44801 Bochum</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32035997</idno><idno type="pmid">32035997</idno><idno type="doi">10.1016/j.jhin.2020.01.022</idno><idno type="wicri:Area/PubMed/Corpus">000B79</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B79</idno><idno type="wicri:Area/PubMed/Curation">000B79</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000B79</idno><idno type="wicri:Area/PubMed/Checkpoint">000468</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000468</idno><idno type="wicri:Area/Ncbi/Merge">000979</idno><idno type="wicri:Area/Ncbi/Curation">000979</idno><idno type="wicri:Area/Ncbi/Checkpoint">000979</idno><idno type="wicri:Area/Main/Merge">000509</idno><idno type="wicri:Area/Main/Curation">000507</idno><idno type="wicri:Area/Main/Exploration">000507</idno><idno type="wicri:Area/an2020/Extraction">000507</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.</title><author><name sortKey="Kampf, G" sort="Kampf, G" uniqKey="Kampf G" first="G" last="Kampf">G. Kampf</name><affiliation wicri:level="1"><nlm:affiliation>University Medicine Greifswald, Institute for Hygiene and Environmental Medicine, Ferdinand-Sauerbruch-Straße, 17475 Greifswald, Germany. Electronic address: guenter.kampf@uni-greifswald.de.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>University Medicine Greifswald, Institute for Hygiene and Environmental Medicine, Ferdinand-Sauerbruch-Straße, 17475 Greifswald</wicri:regionArea><wicri:noRegion>17475 Greifswald</wicri:noRegion><wicri:noRegion>17475 Greifswald</wicri:noRegion><wicri:noRegion>17475 Greifswald</wicri:noRegion></affiliation></author><author><name sortKey="Todt, D" sort="Todt, D" uniqKey="Todt D" first="D" last="Todt">D. Todt</name><affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum</wicri:regionArea><wicri:noRegion>44801 Bochum</wicri:noRegion><wicri:noRegion>44801 Bochum</wicri:noRegion><wicri:noRegion>44801 Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Pfaender, S" sort="Pfaender, S" uniqKey="Pfaender S" first="S" last="Pfaender">S. Pfaender</name><affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum</wicri:regionArea><wicri:noRegion>44801 Bochum</wicri:noRegion><wicri:noRegion>44801 Bochum</wicri:noRegion><wicri:noRegion>44801 Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Steinmann, E" sort="Steinmann, E" uniqKey="Steinmann E" first="E" last="Steinmann">E. Steinmann</name><affiliation wicri:level="1"><nlm:affiliation>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Molecular and Medical Virology, Ruhr University Bochum, Universitätsstrasse 50, 44801 Bochum</wicri:regionArea><wicri:noRegion>44801 Bochum</wicri:noRegion><wicri:noRegion>44801 Bochum</wicri:noRegion><wicri:noRegion>44801 Bochum</wicri:noRegion></affiliation></author></analytic><series><title level="j">The Journal of hospital infection</title><idno type="eISSN">1532-2939</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (drug effects)</term><term>Betacoronavirus (growth & development)</term><term>Coronavirus Infections (transmission)</term><term>Disinfectants (pharmacology)</term><term>Environmental Microbiology</term><term>Humans</term><term>Microbial Viability</term><term>Pneumonia, Viral (transmission)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Désinfectants (pharmacologie)</term><term>Humains</term><term>Infections à coronavirus (transmission)</term><term>Microbiologie de l'environnement</term><term>Pneumopathie virale (transmission)</term><term>Viabilité microbienne</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Disinfectants</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Désinfectants</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Environmental Microbiology</term><term>Humans</term><term>Microbial Viability</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="fr"><term>Humains</term><term>Infections à coronavirus</term><term>Microbiologie de l'environnement</term><term>Pneumopathie virale</term><term>Viabilité microbienne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Currently, the emergence of a novel human coronavirus, SARS-CoV-2, has become a global health concern causing severe respiratory tract infections in humans. Human-to-human transmissions have been described with incubation times between 2-10 days, facilitating its spread via droplets, contaminated hands or surfaces. We therefore reviewed the literature on all available information about the persistence of human and veterinary coronaviruses on inanimate surfaces as well as inactivation strategies with biocidal agents used for chemical disinfection, e.g. in healthcare facilities. The analysis of 22 studies reveals that human coronaviruses such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus or endemic human coronaviruses (HCoV) can persist on inanimate surfaces like metal, glass or plastic for up to 9 days, but can be efficiently inactivated by surface disinfection procedures with 62-71% ethanol, 0.5% hydrogen peroxide or 0.1% sodium hypochlorite within 1 minute. Other biocidal agents such as 0.05-0.2% benzalkonium chloride or 0.02% chlorhexidine digluconate are less effective. As no specific therapies are available for SARS-CoV-2, early containment and prevention of further spread will be crucial to stop the ongoing outbreak and to control this novel infectious thread.</div></front></TEI><affiliations><list><country><li>Allemagne</li></country></list><tree><country name="Allemagne"><noRegion><name sortKey="Kampf, G" sort="Kampf, G" uniqKey="Kampf G" first="G" last="Kampf">G. Kampf</name></noRegion><name sortKey="Pfaender, S" sort="Pfaender, S" uniqKey="Pfaender S" first="S" last="Pfaender">S. Pfaender</name><name sortKey="Steinmann, E" sort="Steinmann, E" uniqKey="Steinmann E" first="E" last="Steinmann">E. Steinmann</name><name sortKey="Todt, D" sort="Todt, D" uniqKey="Todt D" first="D" last="Todt">D. Todt</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/an2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000507 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd -nk 000507 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= an2020
|étape= Analysis
|type= RBID
|clé= pubmed:32035997
|texte= Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/an2020/Analysis/RBID.i -Sk "pubmed:32035997" \
| HfdSelect -Kh $EXPLOR_AREA/Data/an2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a CovidV2
| This area was generated with Dilib version V0.6.33. |  |